![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » TEVA AGAIN HIKES COPAXONE PRICES
TEVA AGAIN HIKES COPAXONE PRICES
Amtech investment house pointed out today a 4% increase in the price of Copaxone, the flagship drug of Israeli pharmaceutical giant Teva Pharmaceutical Industries Ltd. The price hike will apparently boost Tevs's results for the third quarter of this year. Globes (http://www.globes.co.il/serveen/globes/DocView.asp?did=1000125536&fid=1725)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct